Inducible eukaryotic expression system

Details for Australian Patent Application No. 2003237259 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Fandl, James P.; Dou, Changlin

Agent Davies Collison Cave

Pub. Number AU-B-2003237259

PCT Number PCT/US03/16676

PCT Pub. Number WO2003/101189

Priority 60/384,004 29.05.02 US

Filing date 28 May 2003

Wipo publication date 19 December 2003

Acceptance publication date 24 January 2008

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/384,004 29.05.02 US

12 February 2004 Application Open to Public Inspection

  Published as AU-B-2003237259

29 November 2007 Amendment Made

  The nature of the amendment is: Add co-inventor Dou, Changlin

24 January 2008 Application Accepted

  Published as AU-B-2003237259

22 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003237260-NOTCH 1 INHIBITORS FOR INDUCING APOPOTOSIS

2003237258-Use of pullulan as a slowly digested carbohydrate